Clinical Trials Browser

Rhabdomyosarcoma

Carcinoma, Hepatocellular

Neoplasm Metastasis

Lung Neoplasms

Small Cell Lung Cancer Extensive Stage

Lung Diseases, Thoracic Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Hepatocellular

Endometrial Neoplasms

Advanced Liver Cancers

Breast Neoplasms

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Neoplasms

Carcinoma, Hepatocellular, Cholangiocarcinoma

Extensive Stage-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Recurrence

Hodgkin Disease, Recurrence

Carcinoma, Non-Small-Cell Lung

Glioblastoma, Gliosarcoma

Anal Cancer Metastatic

Advanced Solid Tumor

Small Cell Lung Cancer Extensive Stage

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

Lung Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Carcinoma, Hepatocellular

Advanced Solid Tumor

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Lung Neoplasms

Mesothelioma, Malignant, Wilms Tumor

Clinical Trials

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

MK-6070-003

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

EndoMAP

MORPHEUS-LIVER

Morpheus-panBC

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

FIL_A-BEGEV

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

GOBLET

A Study of YL201 in Patients With Advanced Solid Tumors

Acclaim-3

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors

MacroTrans

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

TESSERACT

Immuno-MESODEC